Pregnancy, delivery and lactation in hyperprolactinaemic XXXX .

@entity1 @entity2847 @entity600 @entity4090 @entity751 @entity652
A report is given of 87 pregnancies in hyperprolactinaemic @entity1 treated with @entity2847 . The high @entity4090 level in 11 cases was caused by hypophyseal @entity652 . If the plasma @entity4090 level exceeded 5000 mU/l during pregnancy, @entity2847 was administered until delivery. If the initial @entity4090 value was over 1000 mU/l, the @entity4090 level was measured during pregnancy, delivery and the lactational period. After weaning, the @entity4090 level was again elevated in the majority of cases. During pregnancy, delivery and lactation, complications which differed significantly from the usual were not observed, pregnancy and nursing took place normally. Breast feeding was not contraindicated in any of the cases. Among the newborns, adaptation disturbances and @entity600 , showed the usual frequency. In the authors' opinion pregnancies which occur during the treatment of hyperprolactinaemic @entity1 need increased care. Complications during pregnancy, delivery and nursing period were not more frequently observed either in the mother or the newborn. The @entity751 did not deteriorate during gestation and lactation, but its normalization can not be expected.
